Zobrazeno 1 - 10
of 174
pro vyhledávání: '"M. G., Glezer"'
Autor:
A. V. Azarov, M. G. Glezer, A. S. Zhuravlev, I. R. Rafaeli, S. P. Semitko, K. V. Gyulmisaryan, S. A. Kurnosov
Publikováno v:
Трансплантология (Москва), Vol 15, Iss 4, Pp 464-476 (2023)
Introduction. Therapy of patients with acute ST-elevation myocardial infarction and massive coronary thrombosis (TTG 3) is a far from solved problem of modern medicine, since often in such patients immediate stent implantation is associated with t
Externí odkaz:
https://doaj.org/article/8a71ccde950b48bc9ec8468a822710b9
Autor:
A. V. Azarov, M. G. Glezer, A. S. Zhuravlev, I. R. Rafaeli, S. P. Semitko, K. V. Gyul’misaruyan, S. A. Kurnosov
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 36-43 (2023)
Aim. TIntroduction. To evaluate in-hospital angiographic and five-year posthospital clinical outcomes of percutaneous intervention strategy without stent implantation with immediate coronary artery stenting technique in STEMI patients with massive co
Externí odkaz:
https://doaj.org/article/333decf0b766446ca08b94b7ec8744f6
Autor:
E. V. Shlyakhto, Yu. N. Belenkov, S. I. Boytsov, S. V. Villevalde, A. S. Galyavich, M. G. Glezer, N. E. Zvartau, Zh. Kobalava, Yu. M. Lopatin, Yu. V. Mareev, S. N. Tereshchenko, I. V. Fomin, O. L. Barbarash, N. G. Vinogradova, D. V. Duplyakov, I. V. Zhirov, E. D. Kosmacheva, V. A. Nevzorova, O. M. Reitblat, A. E. Soloveva, E. A. Zorina
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 6 (2023)
Heart failure (HF) is a global health problem. Despite advances in the development of effective treatments for patients with heart failure, morbidity and mortality from remain high, and the prognosis is poor. However, there is potential to improve ou
Externí odkaz:
https://doaj.org/article/81e00cc515b145e79cd24023bb440836
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 4 (2023)
Aim. Based on the results of a sociological survey of patients, to assess quality and availability of health care for cardiovascular diseases (CVDs) in 2020-2021 in the Russian Federation.Material and methods. In August-September 2021, 5159 patients
Externí odkaz:
https://doaj.org/article/a4f94ac1326a456896368142ecdac33a
Autor:
S. A. Boytsov, S. N. Tereshchenko, S. V. Villevalde, A. S. Galyavich, A. A. Garganeeva, M. G. Glezer, D. V. Duplyakov, I. V. Zhirov, Zh. D. Kobalava, Yu. M. Lopatin, S. V. Nedogoda, E. I. Tarlovskaya
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 4 (2023)
The objective of this advisory board meeting was to discuss the place of vericiguat in the treatment algorithm for heart failure with reduced ejection fraction and the necessary requirements for its successful application in clinical practice.
Externí odkaz:
https://doaj.org/article/44182106205149daae9ba73ec79ad3b4
Autor:
T. K. Chernyavskaya, M. G. Glezer
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 49, Iss 2, Pp 125-131 (2021)
Aim: To perform clinical characterization of patients with chronic heart failure (CHF) in the Moscow Region and to assess if their current treatments meet the current clinical guidelines.Materials and methods: Based on the information submitted from
Externí odkaz:
https://doaj.org/article/8284167bd2a94ffda3093cd32faa0377
Autor:
Yu. M. Lopatin, G. P. Arutyunov, A. S. Ametov, F. T. Ageev, M. B. Antsiferov, O. L. Barbarash, S. V. Villevalde, N. G. Vinogradova, G. R. Galstyan, A. S. Galyavich, S. R. Gilyarevsky, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, A. Yu. Lebedeva, S. V. Nedogoda, V. V. Salukhov, E. I. Tarlovskaya, S. N. Tereshchenko, I. V. Fomin, Yu. Sh. Khalimov, D. V. Cherkashin
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 3 (2022)
An online expert meeting held on November 17, 2021 reviewed the results of the randomized, double-blind, multinational, parallel-group EMPULSE trial, evaluating the clinical benefit and safety of the sodium-glucose co-transporter-2 inhibitor (SGLT2i)
Externí odkaz:
https://doaj.org/article/ee648580dd8b4bcaa3917713fdc86a35
Publikováno v:
Cardiology and Therapy, Vol 9, Iss 1, Pp 139-152 (2020)
Abstract Introduction Overweight and obesity are increasing worldwide and are associated with an increased risk for cardiovascular disease (CVD). The aim of this study was to examine the burden of CVD risk factors among normal weight, overweight, and
Externí odkaz:
https://doaj.org/article/6a22dc3bb66d49298da75fd412a2454c
Autor:
S. N. Tereshchenko, M. G. Glezer, S. A. Abugov, O. V. Averkov, S. I. Antipov, A. S. Galyavich, M. Yu. Gilyarov, D. V. Duplyakov, A. A. Efremushkina, D. A. Zateyshchikov, V. V. Ivanenko, E. D. Kosmacheva, O. V. Krestyaninov, Yu. M. Lopatin, E. P. Panchenko, V. V. Ryabov, E. V. Samokhvalov, I. I. Staroverov, S. A. Ustyugov, A. V. Khripun, S. V. Shalaev, R. M. Shakhnovich, I. S. Yavelov, A. N. Yakovlev, S. S. Yakushin
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 11, Pp 92-97 (2019)
The conclusion of the Expert Council reports an agreement on the place of the P2Y12 receptor blocker prasugrel in the early invasive treatment of patients with acute coronary syndrome ACS, according to the results of the multicenter randomized contro
Externí odkaz:
https://doaj.org/article/b0924fb65646460c953c5a5df9f6739a
Autor:
M. G. Glezer, E. I. Astashkin
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 18, Iss 2, Pp 94-103 (2019)
The lecture is devoted to the choice of tactics and the rules of reperfusion therapy for ST-elevated myocardial infarction. Since the time of reperfusion is crucial for the survival of these patients and the preservation of a viable myocardium, prope
Externí odkaz:
https://doaj.org/article/7590df44c1914e10925f75d2dc99c5e0